<?xml version='1.0' encoding='us-ascii'?>
<TimeML xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:noNamespaceSchemaLocation="http://timeml.org/timeMLdocs/TimeML_1.2.1.xsd">
<DOCID>51</DOCID>
<TEXT>
[ * ] = Certain confidential information <EVENT class="COREFERENCE" eid="e0">contained</EVENT> in this document, <EVENT class="COREFERENCE" eid="e1">marked</EVENT> by brackets, has been <EVENT class="COREFERENCE" eid="e2">omitted</EVENT> and <EVENT class="COREFERENCE" eid="e3">filed</EVENT> separately with the Securities and Exchange Commission pursuant to Rule b- of the Securities Exchange Act of , as <EVENT class="COREFERENCE" eid="e4">amended</EVENT> . CONFIDENTIAL EXECUTION VERSION LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT THIS LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (this "Agreement") <EVENT class="COREFERENCE" eid="e5">dated</EVENT> as of May , (the "Effective Date "), is <EVENT class="COREFERENCE" eid="e6">made</EVENT> and <EVENT class="COREFERENCE" eid="e7">entered</EVENT> into by and between Array BioPharma Inc., a company <EVENT class="COREFERENCE" eid="e8">organized</EVENT> under the laws of Delaware and <EVENT class="COREFERENCE" eid="e9">having</EVENT> its principal place of business at Walnut Street, Boulder, CO USA, ("Array") and Ono Pharmaceutical Co., Ltd., a company duly <EVENT class="COREFERENCE" eid="e10">organized</EVENT> and <EVENT class="COREFERENCE" eid="e11">existing</EVENT> under the laws of Japan, <EVENT class="COREFERENCE" eid="e12">having</EVENT> offices and principal place of business at - , Kyutaromachi -chome, Chuo-ku, Osaka - , Japan ("Ono"). BACKGROUND A. Array now <EVENT class="COREFERENCE" eid="e13">owns</EVENT> or <EVENT class="COREFERENCE" eid="e14">controls</EVENT> certain patents, know -how and other intellectual property <EVENT class="COREFERENCE" eid="e15">relating</EVENT> to the Products (as <EVENT class="COREFERENCE" eid="e16">defined</EVENT> below); B. Ono has <EVENT class="COREFERENCE" eid="e17">experience</EVENT> in developing, marketing and <EVENT class="COREFERENCE" eid="e18">distributing</EVENT> pharmaceutical products; C. Array and Ono <EVENT class="COREFERENCE" eid="e19">wish</EVENT> to <EVENT class="COREFERENCE" eid="e20">collaborate</EVENT> on the further <EVENT class="COREFERENCE" eid="e21">development</EVENT> <EVENT class="COREFERENCE" eid="e22">manufacture</EVENT> and <EVENT class="COREFERENCE" eid="e23">commercialization</EVENT> of the Products, with Ono <EVENT class="COREFERENCE" eid="e24">taking</EVENT> the lead role in such <EVENT class="COREFERENCE" eid="e25">efforts</EVENT> in the Ono Territory (as <EVENT class="COREFERENCE" eid="e26">defined</EVENT> below); and D. Array is willing to <EVENT class="COREFERENCE" eid="e27">grant</EVENT> to Ono, and Ono desires to <EVENT class="COREFERENCE" eid="e28">obtain</EVENT> , certain exclusive rights and licenses with respect to the <EVENT class="COREFERENCE" eid="e29">manufacture</EVENT> <EVENT class="COREFERENCE" eid="e30">registration</EVENT> and <EVENT class="COREFERENCE" eid="e31">commercialization</EVENT> of the Products in the Ono Territory. Array will <EVENT class="COREFERENCE" eid="e32">retain</EVENT> the right to <EVENT class="COREFERENCE" eid="e33">develop</EVENT> and <EVENT class="COREFERENCE" eid="e34">commercialize</EVENT> the Products for the Array Territory, all on the terms and conditions set forth herein. NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants herein <EVENT class="COREFERENCE" eid="e35">contained</EVENT> , and for other good and valuable consideration, the <EVENT class="COREFERENCE" eid="e36">receipt</EVENT> and sufficiency of which are hereby <EVENT class="COREFERENCE" eid="e37">acknowledged</EVENT> , the Parties hereby <EVENT class="COREFERENCE" eid="e38">agree</EVENT> as follows : ARTICLE I DEFINITIONS . "Affiliate" of a Party means any person, corporation or other entity that, directly or indirectly, controls, is controlled by, or is under common control with such Party, as the case may be. As <EVENT class="COREFERENCE" eid="e39">used</EVENT> in this Section . , the word "control" ( <EVENT class="COREFERENCE" eid="e40">including</EVENT> , with correlative meaning, the terms "controlled by" or "under the common control with") shall mean the actual power, either directly or indirectly through one or more intermediaries, to direct or cause the direction of the management and policies of such entity, whether by the ownership of more than fifty percent ( %) of the voting share capital in such person, corporation, or other entity, or by contract or otherwise. . "Annual Net Sales" means the Net Sales generated over any given Fiscal Year, or in the case of the Fiscal Year in which the First Commercial <EVENT class="COREFERENCE" eid="e41">Sale</EVENT> of the first Product occurs, the Net Sales generated during the period commencing on the date of such First Commercial <EVENT class="COREFERENCE" eid="e42">Sale</EVENT> and continuing until the end of such Fiscal Year. [ * ] = Certain confidential information <EVENT class="COREFERENCE" eid="e43">contained</EVENT> in this document, <EVENT class="COREFERENCE" eid="e44">marked</EVENT> by brackets, has been <EVENT class="COREFERENCE" eid="e45">omitted</EVENT> and <EVENT class="COREFERENCE" eid="e46">filed</EVENT> separately with the Securities and Exchange Commission pursuant to Rule b- of the Securities Exchange Act of , as <EVENT class="COREFERENCE" eid="e47">amended</EVENT> . . "Applicable Regulatory Exclusivity Period" means with respect to a particular Product and particular country in the Ono Territory, the period commencing upon the <EVENT class="COREFERENCE" eid="e48">receipt</EVENT> of the first grant of Regulatory Exclusivity in such country for such Product ("Initial Regulatory Exclusivity"), and continuing until the later of (i) the <EVENT class="COREFERENCE" eid="e49">expiration</EVENT> of such Initial Regulatory Exclusivity, or (ii) if any subsequent grant of Regulatory Exclusivity is received prior the <EVENT class="COREFERENCE" eid="e50">expiration</EVENT> of the Initial Regulatory Exclusivity, then until the <EVENT class="COREFERENCE" eid="e51">expiration</EVENT> of such additional Regulatory Exclusivity if such <EVENT class="COREFERENCE" eid="e52">expiration</EVENT> would occur after the <EVENT class="COREFERENCE" eid="e53">expiration</EVENT> of the Initial Regulatory Exclusivity. . "Array Know-How" means, subject to Section . (c)(ii), all scientific, medical, technical, manufacturing, marketing, regulatory, market access and other information (including clinical data and other related information generated in compliance with CDISC standards) relating to Binimetinib, Encorafinib, a Product and/or any Companion Diagnostic useful with respect to the <EVENT class="COREFERENCE" eid="e54">Development</EVENT> <EVENT class="COREFERENCE" eid="e55">Manufacturing</EVENT> <EVENT class="COREFERENCE" eid="e56">registration</EVENT> (including <EVENT class="COREFERENCE" eid="e57">registration</EVENT> for MAA) or <EVENT class="COREFERENCE" eid="e58">Commercialization</EVENT> of a Product (including the Data), to the extent Controlled by Array or its Controlled Affiliates as of the Effective Date or during the term of this Agreement, and needed by or reasonably useful to Ono in order for Ono to exercise its rights or perform its obligations under this Agreement. Notwithstanding the foregoing or Section . (Data) below, but subject to Section . (Future Third Party Partners), Array Know-How shall in any case <EVENT class="COREFERENCE" eid="e59">include</EVENT> all such items that are <EVENT class="COREFERENCE" eid="e60">generated</EVENT> by or under authority of Array, or any of its Affiliates, in connection with <EVENT class="COREFERENCE" eid="e61">Development</EVENT> <EVENT class="COREFERENCE" eid="e62">Manufacturing</EVENT> and/or <EVENT class="COREFERENCE" eid="e63">Commercialization</EVENT> of the Product during the term of this Agreement. . "Array Patents" means the Patents Controlled by Array or its Controlled Affiliates as of the Effective Date or during the term of this Agreement that: (a) are <EVENT class="COREFERENCE" eid="e64">listed</EVENT> on Exhibit . ; or (b) but for the license <EVENT class="COREFERENCE" eid="e65">granted</EVENT> under this Agreement, would be <EVENT class="COREFERENCE" eid="e66">infringed</EVENT> by the <EVENT class="COREFERENCE" eid="e67">Development</EVENT> <EVENT class="COREFERENCE" eid="e68">Manufacturing</EVENT> <EVENT class="COREFERENCE" eid="e69">registration</EVENT> <EVENT class="COREFERENCE" eid="e70">packaging</EVENT> or <EVENT class="COREFERENCE" eid="e71">Commercialization</EVENT> of a Product in the Ono Territory ( <EVENT class="COREFERENCE" eid="e72">including</EVENT> the <EVENT class="COREFERENCE" eid="e73">identification</EVENT> of patients who would <EVENT class="COREFERENCE" eid="e74">benefit</EVENT> from the Product <EVENT class="COREFERENCE" eid="e75">based</EVENT> on the presence or absence of <EVENT class="COREFERENCE" eid="e76">selected</EVENT> biomarkers); and (c) all <EVENT class="COREFERENCE" eid="e77">additions</EVENT> <EVENT class="COREFERENCE" eid="e78">divisions</EVENT> <EVENT class="COREFERENCE" eid="e79">continuations</EVENT> <EVENT class="COREFERENCE" eid="e80">substitutions</EVENT> <EVENT class="COREFERENCE" eid="e81">re</EVENT> issues, <EVENT class="COREFERENCE" eid="e82">re</EVENT> examinations, <EVENT class="COREFERENCE" eid="e83">registrations</EVENT> patent term <EVENT class="COREFERENCE" eid="e84">extensions</EVENT> supplemental protection certificates, and <EVENT class="COREFERENCE" eid="e85">renewals</EVENT> of any the Patents <EVENT class="COREFERENCE" eid="e86">listed</EVENT> on Exhibit . or to the extent the same would <EVENT class="COREFERENCE" eid="e87">satisfy</EVENT> the requirements of subsection (b) above. . "Array Territory" means all countries worldwide, excluding the Ono Territory. [ * ] = Certain confidential information <EVENT class="COREFERENCE" eid="e88">contained</EVENT> in this document, <EVENT class="COREFERENCE" eid="e89">marked</EVENT> by brackets, has been <EVENT class="COREFERENCE" eid="e90">omitted</EVENT> and <EVENT class="COREFERENCE" eid="e91">filed</EVENT> separately with the Securities and Exchange Commission pursuant to Rule b- of the Securities Exchange Act of , as <EVENT class="COREFERENCE" eid="e92">amended</EVENT> . . "Binimetinib" means the compound known as MEK , the chemical structure of which is depicted in Exhibit . as well as all salts, non-covalent complexes, hydrates, solvates, chelates, crystal polymorph or radiolabeled equivalent thereof. . "Business Days" means any day other than Saturday , Sunday , a day within Array's company-wide corporate holidays (for Array's obligations) or Ono's company-wide corporate holidays (for Ono's obligations) or any other day on which commercial banks in USA or Japan are authorized or required by law to remain closed. . "Calendar Year" means any period of time commencing on January and <EVENT class="COREFERENCE" eid="e93">ending</EVENT> on the next December unless otherwise noted. . "CDISC" means Clinical Data Interchange Standards Consortium which is an interdisciplinary nonprofit organization that establishes international standards for data <EVENT class="COREFERENCE" eid="e94">collection</EVENT> <EVENT class="COREFERENCE" eid="e95">interchange</EVENT> <EVENT class="COREFERENCE" eid="e96">application</EVENT> and <EVENT class="COREFERENCE" eid="e97">storage</EVENT> for the purpose of promoting <EVENT class="COREFERENCE" eid="e98">interoperation</EVENT> of clinical research data. . "Change in Control" means, with respect to a Party, that any of the following occurs with respect to such Party after the Effective Date : (a) any "person" or "group" (as such terms are <EVENT class="COREFERENCE" eid="e99">defined</EVENT> below) (i) is or <EVENT class="COREFERENCE" eid="e100">becomes</EVENT> the "beneficial owner" (as <EVENT class="COREFERENCE" eid="e101">defined</EVENT> below, except that a "person" or "group" shall be <EVENT class="COREFERENCE" eid="e102">deemed</EVENT> to have "beneficial ownership" of all shares of capital stock or other equity interests if such person or group has the right to <EVENT class="COREFERENCE" eid="e103">acquire</EVENT> , whether such right is exercisable immediately or only after the passage of time), directly or indirectly, of shares of capital stock or other interests ( <EVENT class="COREFERENCE" eid="e104">including</EVENT> partnership interests) of such Party then outstanding and normally <EVENT class="COREFERENCE" eid="e105">entitled</EVENT> (without regard to the <EVENT class="COREFERENCE" eid="e106">occurrence</EVENT> of any contingency) to <EVENT class="COREFERENCE" eid="e107">vote</EVENT> in the <EVENT class="COREFERENCE" eid="e108">election</EVENT> of the directors, managers or similar supervisory positions ("Voting Stock") of such Party <EVENT class="COREFERENCE" eid="e109">representing</EVENT> more than fifty percent ( %) of the total <EVENT class="COREFERENCE" eid="e110">voting</EVENT> power of all outstanding classes of Voting Stock of such Party or (ii) has the power, directly or indirectly, to <EVENT class="COREFERENCE" eid="e111">elect</EVENT> a majority of the members of such Party's board of directors or similar governing body; (b) such Party <EVENT class="COREFERENCE" eid="e112">enters</EVENT> into a <EVENT class="COREFERENCE" eid="e113">merger</EVENT> <EVENT class="COREFERENCE" eid="e114">consolidation</EVENT> or similar <EVENT class="COREFERENCE" eid="e115">transaction</EVENT> with another Person (whether or not such Party is the <EVENT class="COREFERENCE" eid="e116">surviving</EVENT> entity) and as a result of such <EVENT class="COREFERENCE" eid="e117">merger</EVENT> <EVENT class="COREFERENCE" eid="e118">consolidation</EVENT> or similar <EVENT class="COREFERENCE" eid="e119">transaction</EVENT> the Persons that beneficially <EVENT class="COREFERENCE" eid="e120">owned</EVENT> , directly or indirectly, the shares of Voting Stock of such Party immediately prior to such <EVENT class="COREFERENCE" eid="e121">transaction</EVENT> cease to beneficially own, directly or indirectly, shares of Voting Stock of such Party <EVENT class="COREFERENCE" eid="e122">representing</EVENT> at least a majority of the total <EVENT class="COREFERENCE" eid="e123">voting</EVENT> power of all outstanding classes of Voting Stock of the <EVENT class="COREFERENCE" eid="e124">surviving</EVENT> Person in substantially the same proportions as their ownership of Voting Stock of such Party immediately prior to such <EVENT class="COREFERENCE" eid="e125">transaction</EVENT> or [ * ] = Certain confidential information <EVENT class="COREFERENCE" eid="e126">contained</EVENT> in this document, <EVENT class="COREFERENCE" eid="e127">marked</EVENT> by brackets, has been <EVENT class="COREFERENCE" eid="e128">omitted</EVENT> and <EVENT class="COREFERENCE" eid="e129">filed</EVENT> separately with the Securities and Exchange Commission pursuant to Rule b- of the Securities Exchange Act of , as <EVENT class="COREFERENCE" eid="e130">amended</EVENT> . (c) such Party <EVENT class="COREFERENCE" eid="e131">sells</EVENT> or transfers to any Third Party, in one or more related <EVENT class="COREFERENCE" eid="e132">transactions</EVENT> properties or assets <EVENT class="COREFERENCE" eid="e133">representing</EVENT> all or substantially all of such Party's assets to which this Agreement <EVENT class="COREFERENCE" eid="e134">relates</EVENT> . For the purpose of this definition of Change in Control: (i) "person" and "group" have the meanings <EVENT class="COREFERENCE" eid="e135">given</EVENT> such terms under Section (d) and (d) of the United States Securities Exchange Act of and the term "group" <EVENT class="COREFERENCE" eid="e136">includes</EVENT> any group <EVENT class="COREFERENCE" eid="e137">acting</EVENT> for the purpose of <EVENT class="COREFERENCE" eid="e138">acquiring</EVENT> , <EVENT class="COREFERENCE" eid="e139">holding</EVENT> or disposing of securities within the meaning of Rule d- (b)( ) under the aforesaid Act; (ii) a "beneficial owner" shall be determined in accordance with Rule d- under the aforesaid Act; (iii) the terms "beneficially owned" and "beneficially own" shall have meanings correlative to that of "beneficial owner"; and (iv)"Person" means any natural person, corporation, firm, business trust, joint venture, association, organization, company, partnership or other business entity or any government, any agency or political subdivisions thereof. Such "person" or "group" in Section . (a), such <EVENT class="COREFERENCE" eid="e140">surviving</EVENT> Person in Section . (b) or such Third Party in Section . (c) shall be <EVENT class="COREFERENCE" eid="e141">referred</EVENT> to herein as "Acquirer". . "Clinical <EVENT class="COREFERENCE" eid="e142">Studies</EVENT> means any human clinical <EVENT class="COREFERENCE" eid="e143">study</EVENT> of a Product, including without limitation Post-Approval Marketing Clinical <EVENT class="COREFERENCE" eid="e144">Studies</EVENT> . "Combination Product" means any pharmaceutical <EVENT class="COREFERENCE" eid="e145">preparations</EVENT> in any dosage strengths, formulations and methods of <EVENT class="COREFERENCE" eid="e146">administration</EVENT> that combine Binimetinib or Encorafenib and one or more other active ingredients (other than Binimetinib or Encorafenib) in fixed dose combination, whether co-formulated or co-packaged. . "<EVENT class="COREFERENCE" eid="e147">Commercialization</EVENT> means all <EVENT class="COREFERENCE" eid="e148">processes</EVENT> and <EVENT class="COREFERENCE" eid="e149">activities</EVENT> conducted to establish and maintain <EVENT class="COREFERENCE" eid="e150">sales</EVENT> for the Products, including <EVENT class="COREFERENCE" eid="e151">offering</EVENT> for <EVENT class="COREFERENCE" eid="e152">sale</EVENT> <EVENT class="COREFERENCE" eid="e153">distribution</EVENT> <EVENT class="COREFERENCE" eid="e154">detailing</EVENT> <EVENT class="COREFERENCE" eid="e155">selling</EVENT> (including <EVENT class="COREFERENCE" eid="e156">launch</EVENT> , <EVENT class="COREFERENCE" eid="e157">promoting</EVENT> <EVENT class="COREFERENCE" eid="e158">importing</EVENT> <EVENT class="COREFERENCE" eid="e159">exporting</EVENT> market access <EVENT class="COREFERENCE" eid="e160">activities</EVENT> all marketing <EVENT class="COREFERENCE" eid="e161">activities</EVENT> undertaken prior to and after the <EVENT class="COREFERENCE" eid="e162">launch</EVENT> of the Products (including education and advertising <EVENT class="COREFERENCE" eid="e163">activities</EVENT> , <EVENT class="COREFERENCE" eid="e164">branding</EVENT> <EVENT class="COREFERENCE" eid="e165">developing</EVENT> promotional materials, <EVENT class="COREFERENCE" eid="e166">advertising</EVENT> <EVENT class="COREFERENCE" eid="e167">organizing</EVENT> speakers <EVENT class="COREFERENCE" eid="e168">programs</EVENT> and post-marketing safety <EVENT class="COREFERENCE" eid="e169">surveillance</EVENT> and <EVENT class="COREFERENCE" eid="e170">reporting</EVENT> "Commercialize" and "Commercializing" shall have the correlative meanings. . "Companion Diagnostic" means an in vitro diagnostic medical device as defined in the European directive / /EC; for the avoidance of doubt the term Companion Diagnostic includes companion diagnostics for a pharmaceutical product as defined in FDA's "Draft Guidance for Industry and Food and Drug Administration Staff - In Vitro Companion Diagnostic Devices". . "Control" ( <EVENT class="COREFERENCE" eid="e171">including</EVENT> any variations such as "Controlled" and " <EVENT class="COREFERENCE" eid="e172">Controlling</EVENT> "), in the context of intellectual property rights, data and/or other information, means that such Party or its Affiliate owns, is licensed or otherwise possesses rights to such intellectual property, data and/or information, [ * ] = Certain confidential information <EVENT class="COREFERENCE" eid="e173">contained</EVENT> in this document, <EVENT class="COREFERENCE" eid="e174">marked</EVENT> by brackets, has been <EVENT class="COREFERENCE" eid="e175">omitted</EVENT> and <EVENT class="COREFERENCE" eid="e176">filed</EVENT> separately with the Securities and Exchange Commission pursuant to Rule b- of the Securities Exchange Act of , as <EVENT class="COREFERENCE" eid="e177">amended</EVENT> . as applicable, sufficient to <EVENT class="COREFERENCE" eid="e178">grant</EVENT> the applicable license or sublicense under this Agreement, without <EVENT class="COREFERENCE" eid="e179">violating</EVENT> the terms of an agreement with a Third Party in existence as of the time such Party or its Affiliates would first be <EVENT class="COREFERENCE" eid="e180">required</EVENT> hereunder to <EVENT class="COREFERENCE" eid="e181">grant</EVENT> the other Party such (sub)license, right to <EVENT class="COREFERENCE" eid="e182">use</EVENT> or access. . "Controlled Affiliates" means, with respect to a Party, any Affiliate that is controlled (as defined in Section . ) by such Party. . "Data" means, subject to Section . (Ono Know-How) and Section . (c)(ii), any and all research data, pharmacology data, preclinical data, clinical data and/or all Regulatory Filings and/or other regulatory documentation, information and <EVENT class="COREFERENCE" eid="e183">submissions</EVENT> pertaining to, or made in association with an IND, Marketing Approval <EVENT class="COREFERENCE" eid="e184">Application</EVENT> Marketing <EVENT class="COREFERENCE" eid="e185">Approval</EVENT> or Pricing and Reimbursement <EVENT class="COREFERENCE" eid="e186">Approvals</EVENT> or any Post-Approval Marketing Clinical <EVENT class="COREFERENCE" eid="e187">Study</EVENT> for each Product, in each case to the extent Controlled by a Party or its Affiliates as of the Effective Date or during the term of this Agreement. . "<EVENT class="COREFERENCE" eid="e188">Development</EVENT> or " <EVENT class="COREFERENCE" eid="e189">Develop</EVENT> " means non-clinical and clinical research and drug development <EVENT class="COREFERENCE" eid="e190">activities</EVENT> including <EVENT class="COREFERENCE" eid="e191">toxicology</EVENT> <EVENT class="COREFERENCE" eid="e192">pharmacology</EVENT> statistical <EVENT class="COREFERENCE" eid="e193">analysis</EVENT> Clinical <EVENT class="COREFERENCE" eid="e194">Studies</EVENT> (including pre- and post-approval <EVENT class="COREFERENCE" eid="e195">studies</EVENT> Post-Approval Marketing Clinical <EVENT class="COREFERENCE" eid="e196">Studies</EVENT> and Investigator Sponsored Clinical <EVENT class="COREFERENCE" eid="e197">Studies</EVENT> , stability <EVENT class="COREFERENCE" eid="e198">testing</EVENT> <EVENT class="COREFERENCE" eid="e199">formulation</EVENT> process <EVENT class="COREFERENCE" eid="e200">development</EVENT> quality assurance/control <EVENT class="COREFERENCE" eid="e201">development</EVENT> regulatory <EVENT class="COREFERENCE" eid="e202">affairs</EVENT> and regulatory <EVENT class="COREFERENCE" eid="e203">activities</EVENT> pertaining to designing and carrying out Clinical <EVENT class="COREFERENCE" eid="e204">Studies</EVENT> and obtaining and maintaining Marketing <EVENT class="COREFERENCE" eid="e205">Approvals</EVENT> (including pre-marketing <EVENT class="COREFERENCE" eid="e206">activities</EVENT> but excluding regulatory <EVENT class="COREFERENCE" eid="e207">activities</EVENT> directed to obtaining Pricing and Reimbursement <EVENT class="COREFERENCE" eid="e208">Approvals</EVENT> . . "Diligent <EVENT class="COREFERENCE" eid="e209">Efforts</EVENT> means, with respect to the <EVENT class="COREFERENCE" eid="e210">efforts</EVENT> to be expended by a Party, with respect to any objective, reasonable, good faith <EVENT class="COREFERENCE" eid="e211">efforts</EVENT> to accomplish such objective as such Party would normally use to accomplish a similar objective under similar circumstances for such Party's benefit. Without <EVENT class="COREFERENCE" eid="e212">limiting</EVENT> the foregoing, with respect to <EVENT class="COREFERENCE" eid="e213">efforts</EVENT> <EVENT class="COREFERENCE" eid="e214">relating</EVENT> to the <EVENT class="COREFERENCE" eid="e215">Development</EVENT> of, <EVENT class="COREFERENCE" eid="e216">obtaining</EVENT> Marketing <EVENT class="COREFERENCE" eid="e217">Approval</EVENT> or Pricing and Reimbursement <EVENT class="COREFERENCE" eid="e218">Approval</EVENT> for, or <EVENT class="COREFERENCE" eid="e219">Commercialization</EVENT> of the Product, generally or with respect to any particular country, "Diligent <EVENT class="COREFERENCE" eid="e220">Efforts</EVENT> means a sustained, continued and active <EVENT class="COREFERENCE" eid="e221">commitment</EVENT> of <EVENT class="COREFERENCE" eid="e222">efforts</EVENT> and resources by a Party consistent with those normally applied in the pharmaceutical industry with respect to compounds or products with similar market at a similar stage in the product life cycle that such Party is actively developing or commercializing (as applicable), taking into account the stage and risk of <EVENT class="COREFERENCE" eid="e223">development</EVENT> or <EVENT class="COREFERENCE" eid="e224">commercialization</EVENT> of the Product, issues of safety or efficacy, the cost effectiveness of <EVENT class="COREFERENCE" eid="e225">efforts</EVENT> or resources while optimizing profitability, the competitiveness of alternative Third Party compounds, products or generics that are or are expected to be in the marketplace, the scope and duration of Patents or other intellectual property rights related to the compound or product (including any Regulatory Exclusivity), the profitability of the Product (including pricing and reimbursement status achieved or likely to be achieved) or other relevant commercial factors, [ * ] = Certain confidential information <EVENT class="COREFERENCE" eid="e226">contained</EVENT> in this document, <EVENT class="COREFERENCE" eid="e227">marked</EVENT> by brackets, has been <EVENT class="COREFERENCE" eid="e228">omitted</EVENT> and <EVENT class="COREFERENCE" eid="e229">filed</EVENT> separately with the Securities and Exchange Commission pursuant to Rule b- of the Securities Exchange Act of , as <EVENT class="COREFERENCE" eid="e230">amended</EVENT> . but not <EVENT class="COREFERENCE" eid="e231">taking</EVENT> into account (a) any other pharmaceutical product such Party is then <EVENT class="COREFERENCE" eid="e232">researching</EVENT> , <EVENT class="COREFERENCE" eid="e233">developing</EVENT> or commercializing, alone or with one or more collaborators, or (b) any <EVENT class="COREFERENCE" eid="e234">payments</EVENT> <EVENT class="COREFERENCE" eid="e235">required</EVENT> to be <EVENT class="COREFERENCE" eid="e236">made</EVENT> to the other Party hereunder. . "EMA" means the European Medicines Agency, or any successor entity thereto performing similar functions. . "Encorafenib" means the compound known as LGX , the chemical structure of which is depicted in Exhibit . , as well as all salts, non-covalent complexes, hydrates, solvates, chelates, crystal polymorph, or radiolabeled equivalent thereof. . "FDA" means the U.S. Food and Drug Administration, or any successor entity thereto performing similar functions. . "<EVENT class="COREFERENCE" eid="e237">Field</EVENT> means the <EVENT class="COREFERENCE" eid="e238">diagnosis</EVENT> <EVENT class="COREFERENCE" eid="e239">treatment</EVENT> and/or prev<EVENT class="COREFERENCE" eid="e240">ention</EVENT> of diseases and conditions in humans.
</TEXT>
<MAKEINSTANCE aspect="NONE" eiid="ei12899" eventID="e0" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12900" eventID="e1" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12901" eventID="e2" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12902" eventID="e3" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12903" eventID="e4" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12904" eventID="e5" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12905" eventID="e6" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12906" eventID="e7" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12907" eventID="e8" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12908" eventID="e9" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12909" eventID="e10" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12910" eventID="e11" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12911" eventID="e12" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12912" eventID="e13" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12913" eventID="e14" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12914" eventID="e15" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12915" eventID="e16" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12916" eventID="e17" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12917" eventID="e18" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12918" eventID="e19" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12919" eventID="e20" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12920" eventID="e21" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12921" eventID="e22" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12922" eventID="e23" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12923" eventID="e24" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12924" eventID="e25" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12925" eventID="e26" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12926" eventID="e27" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12927" eventID="e28" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12928" eventID="e29" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12929" eventID="e30" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12930" eventID="e31" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12931" eventID="e32" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12932" eventID="e33" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12933" eventID="e34" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12934" eventID="e35" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12935" eventID="e36" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12936" eventID="e37" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12937" eventID="e38" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12938" eventID="e39" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12939" eventID="e40" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12940" eventID="e41" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12941" eventID="e42" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12942" eventID="e43" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12943" eventID="e44" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12944" eventID="e45" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12945" eventID="e46" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12946" eventID="e47" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12947" eventID="e48" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12948" eventID="e49" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12949" eventID="e50" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12950" eventID="e51" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12951" eventID="e52" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12952" eventID="e53" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12953" eventID="e54" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12954" eventID="e55" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12955" eventID="e56" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12956" eventID="e57" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12957" eventID="e58" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12958" eventID="e59" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12959" eventID="e60" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12960" eventID="e61" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12961" eventID="e62" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12962" eventID="e63" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12963" eventID="e64" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12964" eventID="e65" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12965" eventID="e66" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12966" eventID="e67" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12967" eventID="e68" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12968" eventID="e69" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12969" eventID="e70" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12970" eventID="e71" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12971" eventID="e72" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12972" eventID="e73" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12973" eventID="e74" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12974" eventID="e75" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12975" eventID="e76" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12976" eventID="e77" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12977" eventID="e78" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12978" eventID="e79" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12979" eventID="e80" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12980" eventID="e81" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12981" eventID="e82" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12982" eventID="e83" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12983" eventID="e84" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12984" eventID="e85" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12985" eventID="e86" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12986" eventID="e87" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12987" eventID="e88" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12988" eventID="e89" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12989" eventID="e90" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12990" eventID="e91" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12991" eventID="e92" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12992" eventID="e93" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12993" eventID="e94" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12994" eventID="e95" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12995" eventID="e96" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12996" eventID="e97" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12997" eventID="e98" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12998" eventID="e99" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei12999" eventID="e100" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13000" eventID="e101" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13001" eventID="e102" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13002" eventID="e103" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13003" eventID="e104" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13004" eventID="e105" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13005" eventID="e106" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13006" eventID="e107" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13007" eventID="e108" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13008" eventID="e109" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13009" eventID="e110" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13010" eventID="e111" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13011" eventID="e112" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13012" eventID="e113" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13013" eventID="e114" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13014" eventID="e115" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13015" eventID="e116" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13016" eventID="e117" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13017" eventID="e118" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13018" eventID="e119" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13019" eventID="e120" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13020" eventID="e121" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13021" eventID="e122" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13022" eventID="e123" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13023" eventID="e124" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13024" eventID="e125" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13025" eventID="e126" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13026" eventID="e127" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13027" eventID="e128" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13028" eventID="e129" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13029" eventID="e130" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13030" eventID="e131" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13031" eventID="e132" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13032" eventID="e133" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13033" eventID="e134" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13034" eventID="e135" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13035" eventID="e136" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13036" eventID="e137" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13037" eventID="e138" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13038" eventID="e139" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13039" eventID="e140" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13040" eventID="e141" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13041" eventID="e142" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13042" eventID="e143" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13043" eventID="e144" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13044" eventID="e145" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13045" eventID="e146" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13046" eventID="e147" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13047" eventID="e148" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13048" eventID="e149" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13049" eventID="e150" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13050" eventID="e151" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13051" eventID="e152" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13052" eventID="e153" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13053" eventID="e154" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13054" eventID="e155" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13055" eventID="e156" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13056" eventID="e157" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13057" eventID="e158" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13058" eventID="e159" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13059" eventID="e160" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13060" eventID="e161" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13061" eventID="e162" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13062" eventID="e163" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13063" eventID="e164" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13064" eventID="e165" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13065" eventID="e166" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13066" eventID="e167" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13067" eventID="e168" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13068" eventID="e169" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13069" eventID="e170" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13070" eventID="e171" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13071" eventID="e172" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13072" eventID="e173" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13073" eventID="e174" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13074" eventID="e175" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13075" eventID="e176" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13076" eventID="e177" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13077" eventID="e178" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13078" eventID="e179" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13079" eventID="e180" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13080" eventID="e181" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13081" eventID="e182" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13082" eventID="e183" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13083" eventID="e184" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13084" eventID="e185" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13085" eventID="e186" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13086" eventID="e187" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13087" eventID="e188" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13088" eventID="e189" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13089" eventID="e190" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13090" eventID="e191" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13091" eventID="e192" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13092" eventID="e193" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13093" eventID="e194" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13094" eventID="e195" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13095" eventID="e196" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13096" eventID="e197" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13097" eventID="e198" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13098" eventID="e199" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13099" eventID="e200" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13100" eventID="e201" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13101" eventID="e202" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13102" eventID="e203" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13103" eventID="e204" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13104" eventID="e205" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13105" eventID="e206" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13106" eventID="e207" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13107" eventID="e208" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13108" eventID="e209" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13109" eventID="e210" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13110" eventID="e211" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13111" eventID="e212" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13112" eventID="e213" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13113" eventID="e214" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13114" eventID="e215" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13115" eventID="e216" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13116" eventID="e217" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13117" eventID="e218" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13118" eventID="e219" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13119" eventID="e220" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13120" eventID="e221" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13121" eventID="e222" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13122" eventID="e223" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13123" eventID="e224" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13124" eventID="e225" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13125" eventID="e226" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13126" eventID="e227" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13127" eventID="e228" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13128" eventID="e229" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13129" eventID="e230" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13130" eventID="e231" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13131" eventID="e232" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13132" eventID="e233" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13133" eventID="e234" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13134" eventID="e235" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13135" eventID="e236" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13136" eventID="e237" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13137" eventID="e238" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13138" eventID="e239" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13139" eventID="e240" polarity="POS" pos="VERB" tense="NONE" />
</TimeML>